www.escardio.org

Published today - Advanced Access

European Heart Journalhttp://eurheartj.oxfordjournals.org/

www.escardio.org

Classification of Atrial Fibrillation

Paroxysmal(usually <48 h)

www.escardio.org

Time Course and Management of AF

www.escardio.org

Important Elements of the History

www.escardio.org

Symptom Scores

www.escardio.org

Diagnosis / Follow-up Class I Recommendations

www.escardio.org

Principles of Management

www.escardio.org

CHA2DS2-VASc

www.escardio.org

CHA2DS2-VASc Thromboembolic Risk Score

www.escardio.org

Selected OAC Recommendations

www.escardio.org

Bleeding Risk – HAS-BLED Score

www.escardio.org

Rate and Rhythm Control

www.escardio.org

Optimal Rate Control

www.escardio.org

Optimal Rate Control

www.escardio.org

Choice of Rate Control Medication

www.escardio.org

Antiarrhythmic Medication for Rhythm Control

www.escardio.org

Antiarrhythmic Medication for Rhythm Control

www.escardio.org

Antiarrhythmic Medication for Rhythm Control

www.escardio.org

Choice of AAD - Underlying Pathology

www.escardio.org

Catheter Ablation for Atrial Fibrillation

www.escardio.org

Indication for LA Catheter Ablation

www.escardio.org

Ablation whenSHD is Present

www.escardio.org

“Upstream” Therapy Primary PreventionACE inhibitors, Angiotensin receptor blockers, Aldosterone antagonists

Statins, PUFAs

Agents Considered:

www.escardio.org

“Upstream” Therapy – Secondary Prevention

www.escardio.org

Atrial Fibrillation in Athletes

www.escardio.orgEuropean Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)